• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 8.8b: Paclitaxel-Eluting TAXUS Stents: Current Outcomes and Future Directions, Part 2

    Gregg W. Stone, MD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour

    Faculty Disclosure

    Disclosures not available

    Learning Objectives

    • Describe paclitaxel-eluting TAXUS stent (PES) components and drug actions
    • Understand release kinetics of PES
    • Explain the angiographic and clinical results of randomized trials comparing PES and bare metal stents (BMS)
    • Review the Risk/Benefit Analysis of PES vs. BMS
    • Discuss long term safety of PES